3,5-di-tert-butyl-4-hydroxybenzoic acid has been researched along with Hyperlipemia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Kourounakis, AP; Ladopoulou, E; Matralis, AN | 1 |
Athanasekou, C; Rekka, EA; Theodosis-Nobelos, P | 1 |
Kourounakis, A; Lambrinidis, G; Tzara, A | 1 |
3 other study(ies) available for 3,5-di-tert-butyl-4-hydroxybenzoic acid and Hyperlipemia
Article | Year |
---|---|
New multifunctional Di-tert-butylphenoloctahydro(pyrido/benz)oxazine derivatives with antioxidant, antihyperlipidemic, and antidiabetic action.
Topics: Animals; Antioxidants; Atherosclerosis; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Farnesyl-Diphosphate Farnesyltransferase; Hyperlipidemias; Hypoglycemic Agents; Hypolipidemic Agents; Lipoproteins, LDL; Male; Mice; Oxidative Stress; Probucol; Rats | 2013 |
Dual antioxidant structures with potent anti-inflammatory, hypolipidemic and cytoprotective properties.
Topics: Acetaminophen; Animals; Anti-Inflammatory Agents; Antioxidants; Butanes; Carrageenan; Chemical and Drug Induced Liver Injury; Cysteine; Edema; Free Radicals; Hyperlipidemias; Lipid Peroxidation; Oxidative Stress; Parabens; Protective Agents; Rats | 2017 |
Design of Multifaceted Antioxidants: Shifting towards Anti-Inflammatory and Antihyperlipidemic Activity.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Atherosclerosis; Chromans; Drug Design; Humans; Hyperlipidemias; Hypolipidemic Agents; Inflammation; Lipoxygenase; Lipoxygenase Inhibitors; Molecular Docking Simulation; Nerve Degeneration; Oxidative Stress; Parabens; Structure-Activity Relationship | 2021 |